These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 14575985)

  • 1. Breast cancer and hormone-replacement therapy: the Million Women Study.
    Garton M
    Lancet; 2003 Oct; 362(9392):1328; author reply 1330-1. PubMed ID: 14575985
    [No Abstract]   [Full Text] [Related]  

  • 2. Breast cancer and hormone-replacement therapy: the Million Women Study.
    Bundred NJ; Morris J
    Lancet; 2003 Oct; 362(9392):1329; author reply 1330-1. PubMed ID: 14575987
    [No Abstract]   [Full Text] [Related]  

  • 3. Breast cancer and hormone-replacement therapy: the Million Women Study.
    Helmond FA
    Lancet; 2003 Oct; 362(9392):1330; author reply 1330-1. PubMed ID: 14575988
    [No Abstract]   [Full Text] [Related]  

  • 4. Postmenopausal hormone therapy and breast cancer.
    Prescrire Int; 2009 Apr; 18(100):66-7. PubMed ID: 19585723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Postmenopausal hormone therapy--an update. Benefit versus risk--important to identify women with increased breast cancer risk].
    von Schoultz B
    Lakartidningen; 2009 Aug 19-25; 106(34):2041-2. PubMed ID: 19769143
    [No Abstract]   [Full Text] [Related]  

  • 6. Breast cancer risk during hormone therapy: experimental versus clinical data.
    Ruan X; Seeger H; Mueck AO
    Minerva Endocrinol; 2012 Mar; 37(1):59-74. PubMed ID: 22382615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. More about: effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin.
    Magnusson C; Persson I; Adami HO
    J Natl Cancer Inst; 2000 Jul; 92(14):1183-4. PubMed ID: 10904095
    [No Abstract]   [Full Text] [Related]  

  • 8. Hormone replacement therapy containing progestins and given continuously increases breast carcinoma risk in Sweden.
    Shah NR
    Cancer; 2003 Oct; 98(7):1552-3; author reply 1553. PubMed ID: 14508845
    [No Abstract]   [Full Text] [Related]  

  • 9. [Hormone replacement therapy in menopause and risk of breast cancer].
    Clavel-Chapelon F; Hill C
    Presse Med; 2000 Oct; 29(31):1688-93. PubMed ID: 11094609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of breast cancer with progestins in combination with estrogen as hormone replacement therapy.
    Santen RJ; Pinkerton J; McCartney C; Petroni GR
    J Clin Endocrinol Metab; 2001 Jan; 86(1):16-23. PubMed ID: 11231971
    [No Abstract]   [Full Text] [Related]  

  • 11. Polymorphisms in the BRCA1 and ABCB1 genes modulate menopausal hormone therapy associated breast cancer risk in postmenopausal women.
    MARIE-GENICA Consortium on Genetic Susceptibility for Menopausal Hormone Therapy Related Breast Cancer Risk
    Breast Cancer Res Treat; 2010 Apr; 120(3):727-36. PubMed ID: 19672706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Re: Effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin.
    Kuller LH
    J Natl Cancer Inst; 2000 Jul; 92(13):1100-1. PubMed ID: 10880556
    [No Abstract]   [Full Text] [Related]  

  • 13. Estrogen-progestin increases breast cancer risk.
    Stephens MB
    J Fam Pract; 2000 Apr; 49(4):301-2. PubMed ID: 10778832
    [No Abstract]   [Full Text] [Related]  

  • 14. [Increased risk of breast cancer following hormone replacement therapy during climacteric. 3 440 extra cases might have been caused by the treatment in Sweden during the 1990s].
    Magnusson C; Reeves G
    Lakartidningen; 2005 Apr 18-24; 102(16):1228-30. PubMed ID: 15921095
    [No Abstract]   [Full Text] [Related]  

  • 15. Menopause hormone replacement therapy and cancer risk: an Italian record linkage investigation.
    Corrao G; Zambon A; Conti V; Nicotra F; La Vecchia C; Fornari C; Cesana G; Contiero P; Tagliabue G; Nappi RE; Merlino L
    Ann Oncol; 2008 Jan; 19(1):150-5. PubMed ID: 17785762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Understanding breast density and breast cancer risk.
    Peres J
    J Natl Cancer Inst; 2012 Sep; 104(18):1345-6. PubMed ID: 22984197
    [No Abstract]   [Full Text] [Related]  

  • 17. Increased risk of breast cancer following different regimens of hormone replacement therapy frequently used in Europe.
    Stahlberg C; Pedersen AT; Lynge E; Andersen ZJ; Keiding N; Hundrup YA; Obel EB; Ottesen B
    Int J Cancer; 2004 May; 109(5):721-7. PubMed ID: 14999781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postmenopausal estrogen and progestin use in relation to breast cancer risk.
    Newcomb PA; Titus-Ernstoff L; Egan KM; Trentham-Dietz A; Baron JA; Storer BE; Willett WC; Stampfer MJ
    Cancer Epidemiol Biomarkers Prev; 2002 Jul; 11(7):593-600. PubMed ID: 12101105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. So far, victories are few as breast cancer patients sue Wyeth over hormone therapy.
    Twombly R
    J Natl Cancer Inst; 2007 Dec; 99(24):1828-9, 1835. PubMed ID: 18073368
    [No Abstract]   [Full Text] [Related]  

  • 20. Re: effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin.
    Archer DF; Bush T; Nachtigall LE
    J Natl Cancer Inst; 2000 Dec; 92(23):1950-2. PubMed ID: 11106695
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 19.